Medical Cannabis for Autism Spectrum Disorder in Virginia
Some autistic adults explore medical cannabis when anxiety, disrupted sleep, sensory overload, or another health condition continues to affect everyday life.
Parents may also ask a licensed practitioner about medical cannabis when a child has significant related concerns and existing care has not fully addressed the family’s needs.
Here, you’ll find a clear overview of the research, Virginia’s process for adults and minors, important information about THC and CBD, and how the online evaluation works.
Can You Get a Medical Marijuana Card for Autism in Virginia?
Virginia does not use a fixed list of qualifying medical conditions.
A licensed practitioner reviews the patient’s diagnosis, current symptoms, medications, treatments already tried, and how the condition affects daily life. Certification depends on whether the practitioner determines that the patient has a condition that may benefit from medical cannabis.
Autistic adults and families often want to discuss concerns such as:
Significant anxiety or persistent restlessness
Sleep disruption that affects daily function
Severe behavioral dysregulation that has not been fully addressed by current care
Sensory overload that causes significant distress
Co-occurring epilepsy or seizure disorders
Other health concerns that interfere with everyday routines
A Virginia-licensed practitioner can review these concerns during an individual evaluation. The diagnosis alone does not automatically determine the outcome.
Eligibility rules vary by diagnosis and state. You can also review our complete guide to medical marijuana qualifying conditions for more information about conditions patients commonly discuss during an evaluation.
What the Practitioner Reviews During an Autism Evaluation
Autism spectrum disorder is a lifelong neurological and developmental condition that affects each person differently.
Common characteristics may involve social communication, focused interests, repetitive behaviors, sensory processing, or a strong preference for familiar routines.
A medical cannabis evaluation is not intended to change autism or core autistic traits. The practitioner looks at the individual patient and any related health concerns that affect daily life.
The discussion may include:
Anxiety or persistent restlessness
Sleep problems
Sensory overload
Severe behavioral dysregulation
Epilepsy or another seizure disorder
Current medications
Treatments and support already in place
Previous reactions to cannabis or CBD
These concerns do not automatically establish eligibility. They help the practitioner understand the patient’s history, current needs, and whether medical cannabis may be appropriate under Virginia’s case-by-case process.
Autistic Adults and Minors: How the Virginia Process Differs
The evaluation process depends on the patient’s age and ability to participate independently.
Autistic adults
Autistic adults participate directly in the evaluation.
The practitioner reviews the diagnosis, current concerns, medications, existing care, and what the patient hopes to discuss during the appointment.
If the practitioner issues a certification, the patient can access the electronic written certification through the Virginia Cannabis Control Authority Portal.
Minor patients
For a minor patient, a parent or legal guardian must participate in the evaluation and be included on the written certification.
The practitioner reviews the child’s medical history, current care, medications, seizure history, and the family’s concerns before making an individual decision.
A second parent or legal guardian may be added to the certification as a registered agent by the practitioner.
Any product decision for a minor should be discussed with the certifying practitioner and a pharmacist at a licensed dispensary. The child’s age, medications, seizure history, THC sensitivity, and other health factors may affect which options are appropriate.
What Does Current Research Say About Autism and Medical Cannabis?
Researchers have studied cannabis and cannabinoid products in relation to sleep, anxiety, behavioral regulation, social functioning, and other concerns reported by autistic patients and caregivers.
So far, studies have reached different conclusions.
Some small studies and caregiver reports describe changes in certain behaviors or areas of daily functioning. Other studies show limited or inconsistent results. Large, well-designed randomized controlled trials are still needed.
Current research does not show that cannabis treats autism itself.
The American Academy of Child and Adolescent Psychiatry does not recommend medical marijuana for treating the core symptoms of autism in children and adolescents because reliable evidence about safety and effectiveness remains limited.
Families should start with a licensed practitioner, not with product advice from social media, online forums, or anecdotal reports.
How Can Cannabis Affect Autistic People?
People respond to cannabis differently, whether they are autistic or not.
THC is intoxicating. In some people, it may increase anxiety, sensory discomfort, confusion, drowsiness, or coordination problems. These effects may be especially uncomfortable for someone who already experiences significant anxiety or sensory sensitivity.
CBD is non-intoxicating, but CBD-rich cannabis products are not FDA-approved to treat autism.
Small studies have examined sleep, anxiety, behavioral regulation, and social functioning in autistic children and adults. The findings remain preliminary and do not show that cannabis affects every patient in the same way.
Before making a decision, the practitioner reviews factors such as:
Age
Current medications
Seizure history
Mental health history
THC sensitivity
Previous reactions to cannabis or CBD
Current behavioral, developmental, psychiatric, or neurological care
Medical cannabis should not replace existing autism support, behavioral care, mental health treatment, neurological care, or prescribed medication.
What Families Should Know About CBD and THC
THC and CBD affect the body differently.
THC is intoxicating and may increase anxiety, sensory discomfort, confusion, or impairment in some people.
CBD is non-intoxicating, but it is not FDA-approved for treating autism.
The FDA has approved Epidiolex, a prescription form of cannabidiol, for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex.
Epidiolex is approved for those seizure disorders, not for autism.
This is especially important when a patient has both autism and epilepsy. A neurologist should review seizure-related treatment questions separately from a medical cannabis certification evaluation.
Specific products, formats, and cannabinoid profiles should be discussed with the certifying practitioner and a licensed dispensary pharmacist after certification.
For a closer look at strains and product profiles, read our separate guide to cannabis strains commonly discussed in relation to autism.
Adults Previously Diagnosed With Asperger’s Syndrome
Asperger’s syndrome is now included within autism spectrum disorder under the DSM-5.
Adults who previously received an Asperger’s diagnosis may be evaluated through Virginia’s medical cannabis program.
The practitioner reviews the same factors considered for other autistic adults, including current concerns, medications, related conditions, and the effect on daily life.
Certification is not based on the diagnosis name alone.
For information about strains, cannabinoid profiles, and product categories, see our cannabis strains for autism guide.
Is Medical Cannabis FDA-Approved for Autism?
No.
The FDA has not approved cannabis or CBD products to treat autism.
Epidiolex is an FDA-approved prescription cannabidiol medication, but its approved use is limited to seizures associated with certain epilepsy syndromes. It is not approved as an autism treatment.
Families should be cautious with products marketed online as autism treatments, especially when those products promise specific behavioral, developmental, or social outcomes.
What If You Live Outside Virginia?
Medical cannabis eligibility for autism varies by state.
Some programs list autism or refractory autism spectrum disorder as a qualifying condition. Others allow practitioner discretion or require a separate qualifying diagnosis.
Because state rules differ, patients outside Virginia should rely on their own state’s official medical cannabis program.
This page explains Virginia’s process only.
How the Virginia Online Evaluation Works
The appointment can be completed from home through telehealth.
1. Book an online evaluation
Choose an available appointment time and complete the requested patient information before the visit.
2. Meet with a Virginia-licensed practitioner
The practitioner reviews the patient’s health history, current symptoms, medications, existing care, and why medical cannabis is being considered.
3. Include a parent or legal guardian for a minor
For a minor patient, a parent or legal guardian participates in the evaluation and must be included on the written certification if the practitioner certifies the patient.
4. Access the electronic certification
If certified, the patient can access the electronic written certification through the Virginia Cannabis Control Authority Portal.
5. Visit a licensed Virginia dispensary
Bring the required certification information and valid government-issued identification.
A licensed dispensary pharmacist can explain the product categories and labeling available through Virginia’s regulated medical cannabis program.
Because the appointment is online, patients can avoid travel, waiting rooms, and unfamiliar clinical settings. This may make the process more comfortable for autistic adults, minor patients, parents, and caregivers.
What to Do Next?
Autistic adults and families may have questions about related health concerns, Virginia eligibility, safety, or the evaluation process.
During the online evaluation, you can discuss the patient’s history, current medications, existing care, and whether medical cannabis may be appropriate under Virginia law.
You do not need to choose a product or change the patient’s current treatment before the appointment.
Frequently Asked Questions
-
Virginia does not use a fixed qualifying-condition list. A licensed practitioner reviews the patient’s diagnosis, related health concerns, medications, existing care, and how the condition affects daily life.
Certification depends on whether the practitioner determines that the patient has a condition that may benefit from medical cannabis.
-
A parent or legal guardian must participate in the evaluation and be included on the written certification.
The practitioner reviews the child’s medical history, medications, current care, seizure history, and the family’s concerns before making an individual decision.
-
Adults previously diagnosed with Asperger’s syndrome may be evaluated through Virginia’s medical cannabis program.
Certification depends on the practitioner’s review of the individual patient and is not based on the diagnosis name alone.
-
Autistic adults may discuss medical cannabis during an evaluation with a licensed practitioner.
The conversation may include medications, anxiety, sensory sensitivity, seizure history, mental health history, previous cannabis experience, and the concerns that affect daily life.
-
A minor patient may be evaluated through Virginia’s medical cannabis program with the involvement of a parent or legal guardian.
The practitioner reviews the child’s medical history, current care, medications, and related health concerns before deciding whether certification is appropriate.
-
Yes. Small studies and caregiver reports have examined behavioral regulation, sleep, anxiety, and social functioning.
The evidence remains preliminary, and cannabis has not been established as a treatment for autism itself.
-
Current evidence is not strong enough to show that cannabis reliably prevents or manages autistic meltdowns.
Cannabis should not be used during a behavioral crisis without professional guidance. It does not replace behavioral, developmental, psychiatric, or neurological care.
-
No. CBD products are not FDA-approved to treat autism.
Epidiolex, a prescription cannabidiol medication, is approved for seizures associated with certain epilepsy syndromes, not for autism.
-
Smoking exposes the lungs to combustion products and is not appropriate for minors.
Adults considering cannabis should discuss product format, impairment, medications, and safety with a licensed practitioner and dispensary pharmacist.
-
There is no cannabis product proven to be best for autism.
Product decisions depend on the patient’s age, medications, THC sensitivity, seizure history, mental health history, and the products available at licensed dispensaries.
For more detail on strains and product profiles, read our cannabis strains for autism guide.
-
Book an appointment online with CannabisMD TeleMed. The evaluation takes place through telehealth.
For a minor patient, a parent or legal guardian participates in the appointment and must be included on the written certification if the practitioner certifies the patient.
References
Virginia Cannabis Control Authority: Patients, Parents, Legal Guardians, and Registered Agents
Virginia Cannabis Control Authority: Medical Cannabis Practitioners
American Academy of Child and Adolescent Psychiatry: Medical Marijuana and Autism Spectrum Disorder
Systematic Review: Cannabis and Cannabinoid Use in Autism Spectrum Disorder
Systematic Review: Cannabinoids for People With Autism Spectrum Disorder
